Fundamentals of SGLT2i's and GLP-1RA's for CV Risk
Protocols for Safe Use of SGLT2i and GLP1RA in the Hospital Setting
Cardiovascular Benefits of GLP-1 RAs
GLP-1 Meds and Heart Failure Putcomes #zepbound #heart #wegovy
Heart Failure Management: SGLT2i and GLP-1 RA Mechanism of Action
SGLT2 Inhibitors vs GLP-1 Agonists: A Cardiologist and an Endocrinologist Weigh In
SGLT2i and GLP 1RA Cardiac outcomes
How weight loss drugs like Ozempic offer benefits beyond the scale
Using GLP1 receptor agonists to treat cardiac patients with diabetes
Join Dr. Matt Segar as he discusses #GLP1 and its transformative impact on heart health!
GLP-1 Receptor Agonists and Cardiovascular Benefit , LEADER TRIAL ORAL Semgalutide
Optimizing Cardiovascular, Renal Prognosis in Diabetes with GLP-1, SGLT2 Combination
Prof Melanie Davies - 'Do GLP-1 analogues and SGLT2 inhibitors have a role beyond type 2 diabetes?'
Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists
GLP-1 RA and SGLT2 inhibitor in type 2 diabetes
GLP1 RA and Cardiovascular Outcome Trials | IDEC2021
Safe and Effective Use of SGLT2i's and GLP-1RA's in Your Cardiology Practice
Darren K. McGuire | Antihyperglycemic Medications for Cardiovascular Risk Reduction
Evidence-based Management of T2D with ASCVD, CKD, or HF
Obesity and GLP-1 RAs